Long COVID Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 80 years of age
- People with a Body Mass Index (BMI) of 25 or higher (a measure of body weight relative to height)
- People who are not currently pregnant
Who may not be able to join:
For the Arm 2 group (which involves a fat tissue sample procedure):
- People who are pregnant
- People who have previously had liposuction
- People whose weight has changed by more than 2 kg within the past month
- People who have a condition that affects blood clotting
- People who take blood-thinning medications
For the Arm 3 group (healthy controls only):
- People who have a serious disease affecting a major organ (such as the heart, liver, or kidneys)
- People who have diabetes
- People who have previously had liposuction
- People who have had weight-loss (bariatric) surgery
- People with a history of eating disorders
- People with a history of psychiatric disorders
- People who are pregnant or breastfeeding
- People whose weight has changed recently within the past 12 weeks
- People who use weight-loss medications or oral steroid medications
- People whose hematocrit (a measure of red blood cells in the blood) is below 33%
- People whose fasting blood sugar level is 126 mg/dL or higher
- People whose blood pressure is above 160/100 mmHg
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tracey McLaughlin, MD, Stanford School of Medicine
Phone: 6508880144
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Triglyceride/HDL-cholesterol ratio; Concentration of Viral RNA in Adipose Tissue; Rate of Inflammatory Response; Rate of Inflammatory Gene Expression in Adipose Tissue
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.